Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

Sureda, Anna

Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. [electronic resource] - Haematologica Feb 2012 - 310-7 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study

1592-8721

10.3324/haematol.2011.045757 doi


Adolescent
Adult
Europe
Female
Graft vs Host Disease--immunology
Hodgkin Disease--immunology
Humans
Male
Middle Aged
Prospective Studies
Secondary Prevention
Stem Cell Transplantation--methods
Survival Rate
Transplantation Conditioning--methods
Transplantation, Homologous--mortality
Young Adult